Skip to main content
Dan Gombos, MD, Ophthalmology, Houston, TX

Dan S. Gombos MD FACS

Ocular Oncology


Professor & Chief, Section of Ophthalmology MD Anderson Cancer Center

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Dr. Gombos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteChief Residency, Ophthalmology, 1997 - 1998
  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1995 - 1998
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1994

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2002 - 2026
  • CA State Medical License
    CA State Medical License 1995 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • PA State Medical License
    PA State Medical License 1996 - 1998
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Uveal Melanoma Survivor: Specialized Treatment Saved Both My Eyesight and My Life
    Uveal Melanoma Survivor: Specialized Treatment Saved Both My Eyesight and My LifeDecember 4th, 2019
  • Genetic Testing Recommended for Children Considered at Risk for Most Common Eye Cancer
    Genetic Testing Recommended for Children Considered at Risk for Most Common Eye CancerOctober 18th, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: